テキサスにおける高血圧の臨床試験
テキサス内の拠点で、高血圧に関する27件の研究が参加者を募集しています。
テキサス内の都市
- Dallas16件の研究
- Houston11件の研究
- San Antonio7件の研究
- Austin6件の研究
- The Woodlands5件の研究
- Arlington3件の研究
- El Paso3件の研究
- Fort Worth3件の研究
公式研究テキスト(英語)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Bellaire
- Retension Clinical Site, Dallas
- Retension Clincal Site, Plano
- 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Baylor Scott & White Research Institute, Dallas
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- 他25件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Laguna Clinical Research Associates, Laredo
- Tapia Internal Medicine Clinic, Paris
- Baylor Scott and White Research Institute - Temple, Temple
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07511361A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- 他10件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Arlington
- Research Site, Austin
- Research Site, Austin
- 他8件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Plaza Medical Center of Fort Worth, Fort Worth
- Houston Medical Center, Houston
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Allen
- Clinical Trial Site, Amarillo
- Clinical Trial Site, Amarillo
- 他43件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
- University of Texas Southwestern Medical Center, Dallas
被験者募集中早期第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/09/03更新 · NCT04838678IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
被験者募集中健康なボランティア歓迎
18歳以上 · 女性 · 2026/09/02更新 · NCT06218355Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
被験者募集中観察研究健康なボランティア歓迎
0歳〜20歳 · 全性別 · 2026/08/21更新 · NCT04278404Global Paradise System US Post Approval Study
- Ascension Seton, Austin
- Dallas VAMC, Dallas
- TCR Institute, Kingwood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- UT Southwestern Medical Center, Dallas
- University of Texas Health Science Center San Antonio, San Antonio
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
被験者募集中第1/2相
18歳〜100歳 · 全性別 · 2026/08/04更新 · NCT06143566A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Sun Research Institute, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
- Zenos Clinical Research, Dallas
- Aavon Clinical Trials, Houston
被験者募集中
22歳以上 · 全性別 · 2026/07/24更新 · NCT06843577Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
被験者募集中
18歳以上 · 全性別 · 2026/07/20更新 · NCT04163614SPYRAL GEMINI Pilot Study
- Baylor Heart & Vascular Hospital, Dallas
- UT Health East Texas, Tyler
被験者募集中
18歳〜80歳 · 全性別 · 2026/06/24更新 · NCT06907147Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
- University of Texas Medical Branch, Galveston
被験者募集中
18歳以上 · 全性別 · 2026/05/18更新 · NCT05955339The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
- 3100 Cleburne Street, Nabrit Science Building,, Houston
被験者募集中
55歳以上 · 全性別 · 2026/04/13更新 · NCT07413159PRESSURE CHECK: Find Your Path to Better Health
- Houston Methodist, Houston
被験者募集中
18歳以上 · 全性別 · 2026/03/24更新 · NCT06122246Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Carrollton
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- UT Southwestern Medical Center, Dallas
被験者募集中
18歳〜60歳 · 全性別 · 2026/02/10更新 · NCT05168605Preventing Cognitive Decline by Reducing BP Target Trial
- UT Southwestern Medical Center, Dallas
被験者募集中
70歳以上 · 全性別 · 2025/12/03更新 · NCT05106036Targeting Endoplasmic Reticulum Stress in Human Hypertension
- University of North Texas Health Science Center, Fort Worth
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/03/28更新 · NCT06025630ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。